英派斯(002899.SZ):核心肌肉鍛鍊裝置是公司承接國家重大航天項目
格隆匯7月17日丨英派斯(002899.SZ)在互動平臺表示,核心肌肉鍛鍊裝置是公司承接國家重大航天項目,爲太空特殊環境、特殊需求研發,可以提升航天員在失重狀態下的運動協調性和操作穩定性,此款產品目前暫無民用化計劃。但是在正常重力環境下的核心肌肉鍛鍊設備公司已有相關產品上市。該項目順利落地體現了公司在健身器材領域領先的研發能力,公司致力於利用領先的技術優勢與經驗,持續以航天品質爲標準,爲全民打造更加健康、便捷、高效的專業健身器械。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.